IMMX - Immix gains FDA orphan drug status for CAR-T therapy
2023-09-21 12:53:20 ET
More on Immix
- Historical earnings data for Immix Biopharma, Inc.
- Financial information for Immix Biopharma, Inc.
- Immix Biopharma: A Mid-To-Late Stage CAR-T Biotech Quietly Gaining Momentum
- Immix gets FDA orphan drug designation for NXC-201, stock jumps
For further details see:
Immix gains FDA orphan drug status for CAR-T therapy